CENSI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 2.384
EU - Europa 348
AS - Asia 216
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 2.951
Nazione #
US - Stati Uniti d'America 2.381
CN - Cina 190
IT - Italia 182
SE - Svezia 69
FI - Finlandia 30
GB - Regno Unito 24
DE - Germania 17
HK - Hong Kong 10
SG - Singapore 8
FR - Francia 7
UA - Ucraina 5
IE - Irlanda 4
CA - Canada 3
IN - India 3
TR - Turchia 3
BE - Belgio 2
CZ - Repubblica Ceca 2
EU - Europa 2
GR - Grecia 2
BD - Bangladesh 1
DZ - Algeria 1
ES - Italia 1
IQ - Iraq 1
NL - Olanda 1
PL - Polonia 1
SI - Slovenia 1
Totale 2.951
Città #
Fairfield 465
Chandler 244
Ashburn 232
Woodbridge 224
Cambridge 185
Houston 154
Seattle 146
Ann Arbor 137
Wilmington 131
Padova 62
San Diego 54
Beijing 49
Medford 39
Princeton 39
Des Moines 27
Helsinki 26
Boardman 23
Nanjing 15
Jinan 13
Washington 12
Shenyang 11
Hong Kong 10
London 10
Roxbury 9
Cagliari 8
Falls Church 8
Milan 8
Nanchang 8
Tianjin 7
Columbus 6
Guangzhou 6
Los Angeles 6
New York 6
Taizhou 6
Vigonza 6
Changsha 5
Genoa 5
Haikou 5
Hefei 5
Ogden 5
Redwood City 5
Singapore 5
Hebei 4
Kunming 4
Norwalk 4
Castelbellino 3
Cesiomaggiore 3
Fuzhou 3
Jiaxing 3
Kilburn 3
Naples 3
Paris 3
Phoenix 3
Tappahannock 3
Tekirdağ 3
Anguillara Veneta 2
Ardea 2
Borås 2
Brussels 2
Chengdu 2
Dublin 2
Florina 2
Hnevotin 2
Hounslow 2
Isernia 2
Kharkiv 2
Mira 2
New Bedfont 2
Olbia 2
Pisa 2
Pune 2
Rockville 2
Rogliano 2
Schenkendoebern 2
Taiyuan 2
Taranto 2
Temecula 2
Amsterdam 1
Atlanta 1
Bari 1
Bassano del Grappa 1
Brendola 1
Carol Stream 1
Castel 1
Chicago 1
Cittadella 1
Costermano 1
Dallas 1
Ferrara 1
Golmés 1
Guiyang 1
Hangzhou 1
Huzhou 1
Lappeenranta 1
Legnaro 1
Lynbrook 1
Mirpur 1
Montreal 1
Mountain View 1
Ningbo 1
Totale 2.536
Nome #
PROGNOSTIC SIGNIFICANCE OF TERT PROMOTER AND BRAF MUTATIONS IN TIR-4 AND TIR-5 THYROID CYTOLOGY 228
The Hobnail variant of Papillary Thyroid Carcinoma: clinical/molecular characteristics of a large monocentric series and comparison with conventional histotypes 195
Overexpression of L-Type amino acid transporter 1 (LAT1) and 2 (LAT2): Novel markers of neuroendocrine tumors 148
THE NATURAL HISTORY OF AUTOIMMUNE ADDISON'S DISEASE FROM THE DETECTION OF AUTOANTIBODIES TO DEVELOPMENT OF THE DISEASE: A LONG FOLLOW-UP STUDY ON 143 PATIENTS 145
BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience 142
Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients 138
Calcitonin measurement and immunoassay interference: A case report and literature review 106
EF24 (a curcumin analog) and ZSTK474 emphasizes the effect of cabozantinib in medullary thyroid cancer 105
Efficacy of educational intervention to improve awareness of the importance of iodine, use of iodized salt, and dietary iodine intake in northeastern Italian schoolchildren 104
Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma 98
Bone turnover markers, BMD and TBS after short-term, high-dose glucocorticoid therapy in patients with Graves’ orbitopathy: a small prospective pilot study 97
PTH: Redefining Reference Ranges in a Healthy Population-The Role of Interfering Factors and the Type of Laboratory Assay 95
The effects of iodine supplementation in pregnancy on iodine status, thyroglobulin levels and thyroid function parameters: Results from a randomized controlled clinical trial in a mild-to-moderate iodine deficiency area 94
Frequency and significance of Ras, Tert promoter, and Braf mutations in cytologically indeterminate thyroid nodules: A monocentric case series at a tertiary-level Endocrinology unit 92
Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario 85
A Novel Thyroid Hormone Receptor Beta Mutation (G357R) in a Family with Resistance to Thyroid Hormone Beta: Extending the Borders of the "Hot" Region in the THRB Gene 83
Selenium Supplementation, Body Mass Composition, and Leptin Levels in Patients with Obesity on a Balanced Mildly Hypocaloric Diet: A Pilot Study 80
Unique Case of a Large Indolent Medullary Thyroid Carcinoma: Time to Reconsider the Medullary Thyroid Adenoma Entity? 76
Insulin autoimmune syndrome: from diagnosis to clinical management 74
Amiodarone-induced thyrotoxicosis: Differential diagnosis using 99mTc-SestaMIBI and Target-to-Background Ratio (TBR) 72
Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment 71
First proof of association between autoimmune polyglandular syndrome and multiple endocrine neoplasia in humans 63
Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burden 49
The role of the size in thyroid cancer risk stratification 45
Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma 42
Changing dietary habits in veneto region over two decades: Still a long road to go to reach an iodine-sufficient status 42
MicroRNAs in Medullary Thyroid Carcinoma: A State of the Art Review of the Regulatory Mechanisms and Future Perspectives 40
Primary hyperparathyroidism as first manifestation in MEN 2A: an international multicenter study 39
Is this a seizure? 37
Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications 36
Status iodico in gravidanza nella regione del Veneto: impatto sulla funzione tiroidea materna e neonatale e analisi dei determinanti dietetici e socio-economici 34
Epigenetic in medullary thyroid cancer: the role of microRNA in tumorigenesis and prognosis 34
Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows 34
Can ultrasensitive thyroglobulin immunoassays avoid the need for ultrasound in thyroid cancer follow-up? 33
Insulin autoimmune syndrome (Hirata's disease) in an Italian patient: A case report and review of the literature 30
TSH-receptor autoantibodies in patients with chronic thyroiditis and hypothyroidism 27
Expression and clinical utility of transcription factors involved in epithelial–mesenchymal transition during thyroid cancer progression 26
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling 23
null 18
Alemtuzumab-induced autoimmune thyroid events in patients with relapsing-remitting multiple sclerosis: A real-life and monocentric experience at a tertiary-level centre 13
Update on Fundamental Mechanisms of Thyroid Cancer 13
Prophylactic and Early Thyroidectomy in RET Germline Mutation Carriers in Pediatric and Adult Population: Long-Term Outcomes of a Series of 63 Patients 3
Totale 3.009
Categoria #
all - tutte 11.949
article - articoli 11.867
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019125 0 0 0 0 0 0 0 0 0 0 56 69
2019/2020690 39 41 32 88 55 30 93 64 93 79 38 38
2020/2021665 21 48 67 42 16 27 18 51 61 141 77 96
2021/2022611 19 54 68 34 62 48 34 51 56 25 41 119
2022/2023466 89 58 5 84 50 49 6 29 54 17 17 8
2023/2024335 14 32 54 23 41 49 48 16 18 21 19 0
Totale 3.009